NAD+

What it is

NAD+ is the oxidized form of nicotinamide adenine dinucleotide, a coenzyme composed of two nucleotides. It is not a peptide, even though it appears alongside peptides in the catalog. The NAD+/NADH pair participates in electron transfers associated with energy metabolism. NAD+ is also a substrate for enzymes including sirtuins, PARPs, and CD38. These functions support questions about DNA repair, stress responses, and regulation of cellular processes.

Research distinguishes the chemical identity of the material, proposed mechanisms, and observations obtained in each experimental model. A signal measured in cells is not equivalent to an effect demonstrated in people. The catalog presentation is research grade material, not an approved medicine. This description organizes scientific questions and the limits of the evidence; it is not a promise of health changes or a personal recommendation.

Origin

The coenzyme occurs naturally in living cells. Its experimental history began in European laboratories studying fermentation in the early twentieth century; its structure and redox functions were clarified later. Catalog material is manufactured and must be distinguished from the substances examined in studies of its precursors.

How it is studied

Studies use cell cultures, animal models, and human samples to measure NAD+, NADH, mitochondrial respiration, and enzyme activity. Human literature includes extensive work on precursors, which is not equivalent to studying NAD+ itself. Associations with age are distinguished from experimental changes and from any possible clinical consequences for people. Human data are limited for this catalog presentation. Researchers distinguish associations, mechanisms, and experimental changes; these are not interchangeable conclusions. The composition and context of each study matter. These measurements make no promises for people and do not establish the commercial product as an approved medicine.